SILEXION THERAPEUTICS CORP
SLXN · NASDAQ
Updated at 2026-10-13 15:23:11
- Today's High
- $0.19
- Today’s Low
- $0.17
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $0.20
- Previous Close
- $0.17
- Volume
- 1.26M
- Market Cap
- $2.57M
- P/E Ratio
- --
- EPS
- $-56.44
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- THE GOLDYNE SAVAD INST. OF GENE THERAPY, JERUSALEM, ISRAEL, 9112001
- Country
- IL
- Listing Date
- 2021-02-17
- Fiscal Year End
- December
- Shares Outstanding
- 1.06M
- CIK
- 0002022416
- Website
- www.moringaac.com
Biomotion Sciences (SLXN) is a forward-thinking biotechnology firm specializing in regenerative medicine, focused on developing innovative therapies to address severe medical conditions with substantial unmet needs. The company boasts a promising pipeline of product candidates designed to enhance patient care and outcomes significantly. With a commitment to research and development, along with strategic collaborations, Biomotion Sciences is poised to make transformative contributions to the biotechnology landscape, making it an attractive investment prospect for institutional investors interested in advanced therapeutic solutions.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$3.67M
2026-03-31
$2.74M
2025-12-31
-$18.85M
2025-09-30
$3.28M
Net Income
2026-06-30
-$3.55M
2026-03-31
-$2.73M
2025-12-31
-$4.41M
2025-09-30
-$3.26M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-5.17
2026-03-31
$-8.50
2025-12-31
--
2025-09-30
$-28.80
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$3.67M
2026-03-31
-$2.73M
2025-12-31
-$4.4M
2025-09-30
-$3.25M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $3.67M | $2.74M | -$18.85M | $3.28M |
| Net Income | -$3.55M | -$2.73M | -$4.41M | -$3.26M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-5.17 | $-8.50 | -- | $-28.80 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$3.67M | -$2.73M | -$4.4M | -$3.25M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.